Rasmussen, A K, Nielsen, H, Andersen, V et al. · The Journal of rheumatology · 1994
Quick Summary
Researchers compared immune system markers in 21 people with ME/CFS to 21 healthy controls to see if immune problems might cause the illness. They found that people with ME/CFS produced higher levels of certain immune signaling molecules and had slightly different antibody patterns, but overall immune system differences between the groups were small. The study suggests the immune system may be out of balance in ME/CFS, but doesn't prove this imbalance actually causes the disease.
Why It Matters
This study provides early systematic evidence that immune dysregulation exists in ME/CFS, contributing to the biological understanding of the disease beyond purely psychological explanations. The findings support continued investigation into immune mechanisms that might underlie symptom generation and suggest potential biomarkers worth exploring in larger studies.
Observed Findings
Significantly higher in vitro production of interleukin-2 (IL-2) and interferon-gamma (IFN-γ) in CFS patients compared to controls
Serum IgA and IgE concentrations were lower in CFS patients, driven by a higher proportion of controls with elevated values rather than CFS patients having uniformly low values
No significant differences in viral antibody profiles, autoantibody profiles, lymphocyte surface markers, NK cell activity, or lymphocyte proliferative responses
Overall immune system parameters were predominantly similar between CFS and control groups
Inferred Conclusions
The immune system in ME/CFS shows evidence of imbalance, particularly in T cell-derived cytokine production
Immunodeficiency or persistent viral infection do not appear to be primary or uniform mechanisms underlying CFS
Immune abnormalities in CFS, if pathologically significant, are likely subtle and require further investigation with larger cohorts
The relationship between observed immune changes and CFS symptoms remains unclear and may be indirect or secondary
Remaining Questions
Do the elevated IL-2 and IFN-γ levels represent a primary immune dysregulation or a secondary response to other disease processes?
What This Study Does Not Prove
This study does not prove that immune abnormalities cause ME/CFS—it only demonstrates correlation in a small sample. The cross-sectional design cannot establish temporal relationships or whether immune changes precede, follow, or are secondary to other disease processes. The modest differences in most immune measures suggest the immune dysfunction, if present, is complex and not a simple, uniform deficiency.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.